Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Blue Dolphin Energy Company reported Q3 2026 net income of $18.9 million, a significant turnaround from a net loss of $4.7 million in the prior year period. The company saw strong operational performance in its refinery segment, generating $23.9 million in refinery operations EBITDA for the quarter. Cash and cash equivalents improved to $40.8 million as of September 30, 2026, driven by $54.4 million in operating cash flow year-to-date.
Term
Q3 2026
“Blue Dolphin delivered another quarter of strong operational and financial performance by capitalizing on market opportunities. We remain focused on safe, reliable operations, margin capture, capital discipline, and value creation while enhancing refining capacity and capabilities.”
Jonathan P. Carroll, Chief Executive Officer of Blue Dolphin Energy Company
Neighborhood Intelligence, Inc. announced that its Board of Directors has authorized a new share repurchase program to buy back up to $25 million of its outstanding common stock. The program allows for repurchases through open market or private transactions and has no fixed expiration date. This move signals management's commitment to returning capital to shareholders and confidence in the company's valuation.
Firy Inc. reported Q3 2026 revenue of $31.3 million, a 14% year-over-year increase, driven by 141% growth in its RZR segment. The company narrowed its net loss to $12.5 million and reached a debt-free status following the redemption of $49.7 million in senior secured notes in October. Management highlighted progress in collecting a $730 million judgment against Papaya Gaming and expects positive operating cash flow in 2027.
Term
Q3 2026
“We made substantial progress in Q3 2026, with strong execution across the organization driving accelerating momentum in our transition from turnaround to growth. Revenue grew 14% year over year, led by RZR, which grew 141% and for the first time made up the majority of quarterly revenue.”
Andrew Paradise, FIRY CEO
“Our third quarter results highlight the operating leverage in our business. Our net loss narrowed by $4.9 million year over year, and Adjusted EBITDA excluding litigation expense was a loss of $1.2 million, a $6.2 million improvement from a year ago.”
Diversified Healthcare Trust (DHC) filed a formal investor presentation for the NAREIT conference in November 2026. The presentation covers the company's 2026 guidance, senior housing operating portfolio (SHOP) optimization strategy, and strategic capital recycling plans. The filing is intended to provide updates on DHC's balance sheet improvements and asset management strategies to the investment community.
FutureFuel Insider Ronald J. Kruszewski Buys $284K of Stock
Ronald J. Kruszewski bought 100,000 shares of FutureFuel Corp. at $2.84 a share, worth $284K in total on Nov 12, 2026. Shares held after the trade: 110,000 (+1000.0%).
e.l.f. Beauty appointed Amit Khetan, the company's current Chief Accounting Officer, to the additional role of principal accounting officer effective November 12, 2026. He succeeds Mandy Fields in this capacity, who will continue to serve as the company's Senior Vice President and Chief Financial Officer. Mr. Khetan will not receive any additional compensation in connection with this appointment.
Research Solutions reported its first quarter fiscal year 2027 results, highlighted by an 11.5% year-over-year increase in B2B Annual Recurring Revenue (ARR) to $16.5 million. While total revenue slightly decreased to $11.9 million due to lower transaction volume, gross margins improved by 300 basis points to 53.6% as the company continues its strategic shift toward higher-margin platform subscription revenue.
Term
Q1 2027
“Our continued investment in innovation is expanding how researchers discover, access, and engage with scientific literature. Recent launches of Article Galaxy and Scite integrations with ChatGPT, Claude, and Microsoft Copilot bring our capabilities directly into the AI-powered workflows researchers increasingly rely on, making it easier to find trusted evidence and access scholarly content.”
Roy W. Olivier, President and CEO
“Platform revenue accounted for 45% of total revenue this quarter, up from 42% a year ago, reflecting our continued transition toward a higher-margin, recurring revenue model. This evolution is strengthening profitability and operating cash flow, enabling us to reinvest in sales capacity and product innovation to accelerate long-term growth.”
LifeStance Health Group Insider TPG Gp a LLC Sells $485M of Stock
TPG Gp a LLC sold 37,233,110 shares of LifeStance Health Group, Inc. at $13.02 a share, worth $485M in total on Nov 12, 2026. Shares held after the trade: 42,458,592 (-46.7%).
Merck & Co EVP&Pres, Merck Animal Heallth Richard R. DeLuca Sells $8.61M of Stock
Richard R. DeLuca, EVP&Pres, Merck Animal Heallth, sold 58,185 shares of Merck & Co., Inc. at $148.01 a share, worth $8.61M in total on Nov 12, 2026. Shares held after the trade: 112,955 (-34.0%).
CV Sciences Insider Charlie E. Cheever III Buys $45.6K of Stock
Charlie E. Cheever III bought 4,557,721 shares of CV Sciences, Inc. at $0.01 a share, worth $45.6K in total between Nov 4, 2026 and Nov 9, 2026. Shares held after the trade: 31,706,432 (+6.7%).
Senseonics Holdings Director Douglas A. Roeder Buys $176K of Stock
Douglas A. Roeder, Director, bought 17,041 shares of Senseonics Holdings, Inc. at $10.32 a share, worth $176K in total on Nov 13, 2026. Shares held after the trade: 189,712 (+9.9%).
MarineMax is pursuing a growth strategy focused on acquisitions, new retail locations, and digital channel expansion, while navigating risks related to manufacturer approvals and integration. The company faces significant international exposure, particularly regarding foreign currency fluctuations and geopolitical tensions involving suppliers in Italy, Poland, Taiwan, and China.
Ligand Pharmaceuticals Insider Martine Zimmermann Sells $636K of Stock
Martine Zimmermann sold 2,000 shares of Ligand Pharmaceuticals Inc at $318.17 a share, worth $636K in total on Nov 12, 2026. Shares held after the trade: 1,782 (-52.9%).
Reliability Inc. reported a net loss of $417,000 for the nine months ended September 30, 2026, compared to a $742,000 loss in the prior year period. A significant balance sheet change occurred in mid-2026 when the company acquired 253,292,210 treasury shares in a non-cash settlement of related-party notes receivable, resulting in a total shareholders' deficit of $200,000.
HealthLynked Corp reported a significant decline in total revenue to $0.83 million for the nine months ended September 30, 2026, compared to $1.76 million in the prior year. The company's net loss widened to $3.33 million, driven largely by a $2.43 million loss on the change in fair value of debt, despite a reduction in total operating expenses.
Insight Molecular Diagnostics Inc. (iMDx) reported a net loss of $19.1 million for the nine months ended September 30, 2026, an improvement from a $27.3 million loss in the prior year period. The company's financial position remains under pressure with a total shareholders' deficit of $24.2 million and a significant contingent consideration liability of $35.3 million.
Beasley Broadcast Group reported a significant net income of $75.4 million for the nine months ended September 30, 2026, primarily driven by a $91.8 million gain on debt restructure. However, the company faced operational challenges, including a $13.1 million FCC license impairment loss and a decline in net revenue from $152.9 million to $129.5 million year-over-year.
Elite Performance Holding Corp. reported zero revenue for the nine months ended September 30, 2026, resulting in a net loss of $784,601. The company's financial position remains strained with a total stockholders' deficit of $3,653,505 and total liabilities of $3,773,501 against only $119,996 in total assets.
Empire Petroleum reported third quarter 2026 financial results with total product revenue of $10.4 million and a net loss of $3.5 million. Operationally, the company advanced its Texas development program in the Fort Trinidad Field, successfully re-entering the Wakefield-Harrison GU B #1 well to a depth of 21,006 feet to evaluate deep productive zones.
Apimeds Pharmaceuticals US, Inc. reported a net loss of $21.6 million for the nine months ended September 30, 2026, compared to a $4.8 million loss in the prior year. The company transitioned its operations, recording its first software development revenue of $2.48 million while managing a significant digital asset portfolio valued at $142.4 million.
Renasant Corporation has filed its Third Quarter 2026 Investor Presentation, which management will use for meetings with investors during the fourth quarter of 2026. The presentation provides updates on the company's financial performance, business strategy, and objectives.
Research Solutions reported total revenue of $11.9 million for the quarter ended September 30, 2026, a slight decrease from $12.3 million in the prior year, though net income improved to $765,252. The company continues to transition towards its SaaS Platform business, which saw revenue growth, while Transaction-based revenue declined.
Blue Dolphin Energy Company reported 14,921,968 shares of common stock outstanding as of November 16, 2026. The filing highlights a significant corporate structure where Jonathan Carroll and LEH affiliates own 85.1% of the company, and notes the reunification of BOEM and BSEE into the Marine Minerals Administration effective July 2026.
Onfolio Holdings reported a significant decrease in total revenue to $4.7 million for the nine months ended September 30, 2026, compared to $8.7 million in the prior year. The company experienced a substantial net loss driven by a massive $15.2 million interest expense, contributing to an accumulated deficit of over $42 million.
GT Biopharma reported a net loss of $10.88 million for the nine months ended September 30, 2026, compared to a loss of $22.65 million in the prior year period. The company transitioned to a fully remote model as of July 2024 and maintained a cash balance of $9.92 million as of the reporting date.
Perfect Moment Ltd. reported a net loss of $5.58 million for the six months ended September 30, 2026, a slight improvement from the $5.66 million loss in the prior year period. Total assets increased to $18.27 million from $12.23 million, primarily driven by higher inventory levels and accounts receivable, while the company's shareholders' deficit widened to $3.91 million.
Neuphoria Therapeutics Inc., formerly Bionomics Limited, completed its re-domiciliation from Australia to Delaware in December 2024. As of November 13, 2026, the company reported 5,411,334 shares of common stock outstanding and is currently pursuing a proposed merger with Scancell Holdings plc.
Biotricity Inc. reported revenue of $8.61 million for the six months ended September 30, 2026, a 11% increase year-over-year. Despite achieving positive income from operations of $0.50 million, the company recorded a net loss attributable to common stockholders of $2.02 million due to significant interest expenses and derivative liability adjustments.
Automatic Data Processing, Inc. held its Annual Meeting of Stockholders on November 11, 2026. Shareholders elected 13 directors to the board, approved executive compensation on an advisory basis, and ratified the appointment of Deloitte & Touche LLP as the independent accounting firm for the fiscal year beginning July 1, 2026.